成人起病Still病的疾病负担:健康相关生活质量、效用值、成本与资源利用的系统综述
该系统综述检索12个数据库、4个会议及3个技术评估与监管机构网站,纳入16项研究,评估成人起病Still病(AOSD)的健康相关生活质量、效用值、成本和医疗资源利用数据。多数量表SF-36受损,活动期AOSD各子量表均值低于非活动期;生物制剂治疗显示SF-36躯体健康总结改善;效用值显著低于健康对照;直接经济成本数据有限但报告数额可观;住院时间6.1至23.5天。
要点
- AOSD患者SF-36多数量表受损,躯体活动相关维度尤著;活动期各子量表均值低于非活动期。
- 生物制剂治疗显示SF-36躯体健康总结改善;效用值(一项研究)显著低于健康对照。
- 直接经济成本数据有限但报告数额可观,住院时间6.1至23.5天;未检索到间接成本数据。
核心结论
- 该系统综述显示,报告AOSD健康相关生活质量和成本负担的研究匮乏。
研究设计与样本
- 系统综述于2022年8月检索12个数据库、4个会议及3个技术评估与监管机构网站,并核查2017年以来发表的系统综述参考文献列表,共纳入16项研究。
主要发现
- 8项研究报告健康相关生活质量结局,其中1项同时报告效用值数据;2项报告直接成本结局,7项报告医疗资源利用数据;未检索到间接成本数据。
- AOSD患者SF-36多数量表受损,躯体活动相关维度尤著;活动期AOSD患者SF-36各子量表均值低于非活动期AOSD患者。
- 生物制剂治疗显示SF-36躯体健康总结改善;效用值(一项研究)在AOSD患者中显著低于健康对照。
- 直接经济成本数据有限,但报告的成本数额可观;住院时间范围为6.1至23.5天。
局限性
- 报告结局指标多样,限制了跨研究结果的可比性。
- 报告AOSD健康相关生活质量和成本负担的研究匮乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult-onset Still's disease (AOSD) poses a not well estimated burden on patients and healthcare systems. To assess this burden, a systematic review (SR) was undertaken to identify health-related quality of life (HRQoL), utilities, costs and healthcare resource use data. Searches of twelve databases, four conferences, and three key technology assessment and regulatory agency websites were conducted in August 2022. Reference lists of retrieved SRs published since 2017 were also checked. Overall, 16 studies were eligible for inclusion. Eight studies reported HRQoL outcomes, one of which also reported utilities data. Two studies reported direct costs outcomes, and seven reported healthcare resource use data. No indirect costs were identified. A range of outcomes were reported, thus limiting the comparability of results across studies. SF-36 data were impaired in AOSD on most scales, especially those concerning physical activity. Mean SF-36 data were lower across all subscales in patients with active AOSD compared with inactive AOSD. Biologic therapy showed improvements in the SF-36 physical health summary. Utility scores (one study) were significantly lower for AOSD than for healthy controls. Limited direct economic costs data were identified but were substantial where reported. Hospital length of stay ranged from 6.1 to 23.5 days. The SR showed there is a paucity of research reporting the HRQoL and cost burden of AOSD.
引用
- Ruscitti P, Feist E, Canon-Garcia V, et al. Burden of adult-onset Still's disease: A systematic review of health-related quality of life, utilities, costs and resource use. Semin Arthritis Rheum. 2023. PMID: 37802002. doi:10.1016/j.semarthrit.2023.152264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。